US Approves Major New Arms Sales Worth Nearly $16 Billion: Israel and Saudi Arabia Defense Authorization Strengthens Regional Security

Friday’s State Department announcement confirmed $15.67 billion in military equipment approvals for Israel ($6.67 billion) and Saudi Arabia ($9 billion), marking a major expansion of American security commitments in the Middle East. The timing of these approvals coincides with ongoing efforts to maintain the fragile Gaza ceasefire while addressing broader regional security concerns, including potential U.S. military actions against Iran.
Israeli procurement emphasizes Apache helicopters, tactical vehicles, armored upgrades, and utility aircraft across four categories designed to enhance multiple operational capabilities. The Apache attack helicopters constitute the largest single component at $3.8 billion for 30 aircraft complete with rocket launchers and advanced targeting gear, providing Israeli forces with enhanced precision strike capabilities and improved surveillance capacity for diverse mission requirements.
The 3,250 light tactical vehicles valued at $1.98 billion will transform how Israeli Defense Forces deploy personnel and logistics, enabling rapid response across extended geographic areas while strengthening communication networks and supply chain efficiency. The $740 million allocated for power packs will modernize armored personnel carriers that have been in service since 2008, ensuring continued operational effectiveness. The $150 million for light utility helicopters will expand aerial support capacity to complement existing platforms.
Saudi investment targets Patriot missile air defense systems exclusively, with 730 missiles and supporting infrastructure designed to enhance protection against airborne threats. According to the State Department, this enhanced capability will protect land forces of Saudi Arabia, the United States, and local allies, while significantly improving Saudi Arabia’s contribution to the integrated air and missile defense system in the Gulf Region.
Political controversy surrounds congressional oversight and approval timeline, with Democratic leadership questioning the expedited process. Representative Gregory Meeks accused the Trump administration of rushing to announce the deals in a way that would disregard congressional oversight and years of standing practice, while blatantly ignoring long-standing congressional prerogatives and refusing to engage Congress on critical questions about the next steps in Gaza and broader U.S.-Israel policy.